Used in pharmaceutical research as a potent and selective inhibitor of kinases involved in inflammatory and autoimmune diseases. Shows promise in modulating signaling pathways related to immune cell activation, making it a candidate for development in treatments targeting conditions such as rheumatoid arthritis and lupus. Its structure allows for high binding affinity to specific kinase targets, improving efficacy and reducing off-target effects. Also investigated for oncology applications due to its ability to interfere with cell proliferation and survival pathways in certain cancer types. Suitable for in vitro and in vivo studies requiring precise kinase modulation.